Targeting protein misfolding with CRISPR-based chaperone engineering
protein misfolding
CRISPR
chaperone engineering
neurodegenerative diseases
synthetic biology
Mitigating neurodegenerative diseases through inflammasome inhibition in microglia
neuroinflammation
inflammasome
microglia
neurodegeneration
Alzheimer's disease
Through inflammasome inhibition for neurodegenerative disease mitigation
inflammasome
neuroinflammation
Alzheimer’s
Parkinson’s
neurodegeneration
Exploring the role of gut-brain axis modulation in neurodegenerative disease progression
gut-brain axis
neurodegeneration
microbial metabolites
neural signaling
Parkinson's disease
Advancing neurodegenerative disease treatments through inflammasome inhibition mechanisms
neuroinflammation
NLRP3 inhibitors
microglia activation
blood-brain barrier
cytokine storm
Exploring the role of gut microbiome ecosystems in modulating neurodegenerative disease progression
microbiome
neurodegeneration
neuroinflammation
bacterial metabolites
gut-brain axis
Engineering viral vectors for targeted epigenetic reprogramming in neurodegenerative therapies
viral vectors
epigenetic reprogramming
neurodegenerative diseases
gene therapy
CRISPR
Using plasma membrane repair mechanisms to enhance cellular resilience in neurodegenerative diseases
plasma membrane repair
neurodegeneration
cell biology
therapeutic strategies
membrane dynamics
Exploring protein misfolding dynamics within quantum coherence windows for neurodegenerative disease insights
quantum biology
protein aggregation
neurodegeneration
coherence times
amyloid fibrils
Epigenetic reprogramming of aged cells for targeted tissue regeneration in neurodegenerative diseases
epigenetic reprogramming
neurodegeneration
cellular aging
tissue regeneration
CRISPR
Targeting protein misfolding in neurodegenerative diseases with small-molecule chaperones
protein misfolding
neurodegenerative diseases
small-molecule chaperones
drug discovery
amyloid aggregation
Targeting prion disease reversal through CRISPR-based protein misfolding correction
prion diseases
CRISPR
neurodegeneration
protein misfolding
gene therapy